ARDT (Ardent Health, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by ARDT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Dave Caspers | CEO and President | A | — | — |
| 2026-06-08 | ALFRED LUMSDAINE | Chief Financial Officer | Buy | — | — |
| 2026-06-08 | Robert DeMichiei | Director | Buy | — | — |
| 2026-04-02 | Rahul Sen | Director | A | — | — |
| 2026-04-02 | Peter J. Bulgarelli | Director | A | — | — |
| 2026-04-02 | Robert Thomas Webb | Director | A | — | — |
| 2026-04-02 | WILLIAM M GOODYEAR | Director | A | — | — |
| 2026-04-02 | Ellen Havdala | Director | A | — | — |
| 2026-04-02 | Dave Caspers | Chief Operating Officer | MIXED | — | — |
| 2026-04-02 | PETER C B BYNOE | Director | A | — | — |
| 2026-04-02 | Suzanne Campion | Director | A | — | — |
| 2026-04-02 | ALFRED LUMSDAINE | Chief Financial Officer | MIXED | — | — |
| 2026-04-02 | Robert DeMichiei | Director | A | — | — |
| 2026-04-02 | David Raynor Byers | SVP & Chief Accounting Officer | MIXED | — | — |
| 2026-04-02 | Mark R Sotir | Director | A | — | — |
| 2026-04-02 | Edmondo Robinson | Director | A | — | — |
| 2026-04-02 | Stephen C. Petrovich | EVP, GC and Secretary | MIXED | — | — |
| 2026-04-02 | Martin Bonick | President and CEO | MIXED | — | — |
| 2026-03-13 | Ethan Chernin | President of Health Services | A | — | — |
| 2026-03-13 | Martin Bonick | President and CEO | A | — | — |
| 2026-03-13 | David Raynor Byers | SVP & Chief Accounting Officer | A | — | — |
| 2026-03-13 | ALFRED LUMSDAINE | Chief Financial Officer | A | — | — |
| 2026-03-13 | Stephen C. Petrovich | EVP, GC and Secretary | A | — | — |
| 2025-09-30 | David Raynor Byers | SVP & Chief Accounting Officer | F | — | — |
| 2025-09-30 | ALFRED LUMSDAINE | Chief Financial Officer | F | — | — |
| 2025-09-30 | Stephen C. Petrovich | EVP, GC and Asst. Secretary | F | — | — |
| 2025-04-04 | Robert DeMichiei | Director | A | — | — |
| 2025-04-02 | David Schultz | President Hospital Operations | MIXED | — | — |
| 2025-04-02 | Stephen C. Petrovich | EVP, GC and Asst. Secretary | MIXED | — | — |
| 2025-04-02 | ALFRED LUMSDAINE | Chief Financial Officer | MIXED | — | — |
| 2025-04-02 | Ethan Chernin | President of Health Services | MIXED | — | — |
| 2025-04-02 | Martin Bonick | President and CEO | MIXED | — | — |
| 2025-04-02 | David Raynor Byers | SVP & Chief Accounting Officer | MIXED | — | — |
| 2025-04-02 | Dave Caspers | Chief Operating Officer | MIXED | — | — |
| 2025-03-25 | Ellen Havdala | Director | A | — | — |
| 2025-03-25 | WILLIAM M GOODYEAR | Director | A | — | — |
| 2025-03-25 | Edmondo Robinson | Director | A | — | — |
| 2025-03-25 | PETER C B BYNOE | Director | A | — | — |
| 2025-03-25 | Suzanne Campion | Director | A | — | — |
| 2025-03-25 | Robert Thomas Webb | Director | A | — | — |
| 2025-03-25 | Rahul Sen | Director | A | — | — |
| 2025-03-25 | Mark R Sotir | Director | A | — | — |
| 2024-12-16 | Suzanne Campion | Director | A | — | — |
| 2024-12-16 | Robert Thomas Webb | Director | A | — | — |
| 2024-12-16 | Edmondo Robinson | Director | A | — | — |
| 2024-12-16 | PETER C B BYNOE | Director | A | — | — |
| 2024-12-16 | WILLIAM M GOODYEAR | Director | A | — | — |
| 2024-12-16 | Ellen Havdala | Director | A | — | — |
| 2024-11-13 | Robert Thomas Webb | Director | Buy | — | — |
| 2024-09-27 | David Raynor Byers | SVP & Chief Accounting Officer | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | President and CEO | 1,437,937 | — |
| — | EVP, GC and Secretary | 960,932 | — |
| — | Chief Financial Officer | 329,183 | — |
| — | CEO and President | 174,930 | — |
| — | SVP & Chief Accounting Officer | 118,907 | — |
| — | Director | 115,367 | — |
| — | Director | 115,367 | — |
| — | Director | 115,367 | — |
| — | Director | 78,215 | — |
| — | President of Health Services | 68,396 | — |
| — | Director | 58,215 | — |
| — | Director | 58,215 | — |
| — | Director | 38,709 | — |
| — | Director | 38,709 | — |
| — | President Hospital Operations | 37,187 | — |
| — | Director | 35,564 | — |
| — | Director | 14,231 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ARDT quote page; the site-wide leaderboard is on the insider transactions hub.